Headache

In medicine a headache or cephalalgia is a symptom of a number of different conditions of the head. Some of the causes are benign while others are medical emergencies.

What is a Headache?

Headache is a common health complaint that affects millions of people in the UK. In the majority of cases, headache is not serious and can be easily treated with medication or lifestyle changes such as reducing stress or ensuring a good level of hydration.

Types of Headaches

Headache Causes and Triggers

Using a Headache Diary

What is Sinus Headache?

What is Tension Headache?

What is Vascular Headache?

What is a Cluster Headache?

What is Muscle Contraction Headache?

What is Medication Overuse Headache?

Can Contact Lenses Cause Headaches?

Headaches in Children

See more featured articles »

Headache Related to Eye Problems

Headaches in Children and Teenagers

Headache Evaluation in Children and Teenagers

Body Posture and Migraines

Migraine with Aura vs. Migraine without Aura

Biofeedback Therapy for Headaches

Frequent Headaches after a Traumatic Brain Injury

Does the Location of a Headache Matter?

Cluster Headaches: Treatment and Prevention

Latest Headache News and Research

COVID-19 vaccination breakthrough infections in a real-world setting

Researchers describe the pattern and characteristics of infections after COVID-19 vaccination.

13 Jan 2022

Association of vaccination status with Long COVID symptoms

Scientists examined whether vaccination was associated with reporting long-term symptoms post-SARS-CoV-2 infection.

10 Jan 2022

From laboratory to clinic - Nanotechnology-enabled mRNA COVID-19 vaccines

In a recently published article in the journal Nano-Micro Letters, scientists have provided an in-depth review on the application and benefits of nanotechnology in the development of coronavirus disease 2019 (COVID-19) vaccines.

7 Jan 2022

Melatonin found to inhibit SARS-CoV-2 entry into mice brains

New research recently unveiled the utility of melatonin and melatonin-derived medicines in reducing brain entry of severe acute respiratory syndrome coronavirus 2 and subsequently preventing long-term neurological consequences of coronavirus disease 2019.

6 Jan 2022

Both symptomatic and asymptomatic COVID-19 associated with increased risk of cardiovascular events

Researcers determine the risk of symptomatic and asymptomatic SARS-CoV-2 infection on post-acute cardiovascular events and all-cause mortality.

4 Jan 2022

Exercise performance in vaccinated and unvaccinated individuals previously infected with SARS-CoV-2

A cross-sectional report from Israel demonstrated the protective effect of BNT162b2 mRNA vaccine (Pfizer–BioNTech) even after mild to moderate COVID-19).

4 Jan 2022

COVID-19 vaccine appears safe in children aged 5–11 Years

A new report notes menial or nil severe adverse events from vaccination against COVID-19 in children and therefore recommends COVID-19 vaccination among children aged 5-11 years old.

31 Dec 2021

Exploring immunogenicity and safety after a homologous booster dose of SARS-CoV-2 recombinant spike protein vaccine

Research suggests that a single booster dose of NVX-CoV2373 given approximately six months after the primary series induced significant increases in humoral antibodies, while also exhibiting an acceptable safety profile.

29 Dec 2021

Ad5-nCoV vaccine safe and effective against symptomatic, severe COVID-19, trials shows

One dose of Ad5-nCoV (Convidecia), a COVID-19 vaccine developed in China, is 57.5% effective against symptomatic COVID-19 and 91.7% effective against severe COVID-19 disease beginning 28 days postvaccination, according to a phase 3 randomized controlled trial published in The Lancet.

23 Dec 2021

CDC investigates Listeria outbreaks linked to packaged salads

CDC is currently investigating two separate Listeria outbreaks, both of which are linked to packaged salads. One outbreak is linked to packaged salads produced by Fresh Express.

23 Dec 2021

An anesthesiology practice’s busy day in court collecting on surprise bills

Owen Loney's surprise bill resulted from an emergency appendectomy in 2019 at a Richmond, Virginia, hospital.

23 Dec 2021

Children with isolated symptoms as likely as those with multiple symptoms to test COVID-19 positive

A new study compares rates of coronavirus disease 2019 infection in children who reported no symptoms, one isolated symptom, or two or more symptoms during the circulation of the Delta variant.

21 Dec 2021

Primary responses to SARS-CoV-2 in COVID-19 naïve vaccinees

Researchers evaluated primary responses in SARS-CoV-2-naïve vaccinees, as well as secondary responses in the SARS-CoV-2-infected vaccines, and observed a clear set of differences in their clinical symptoms, antibody levels, and cellular and mucosal immune responses.

17 Dec 2021

WHO supports Nigeria in responding to the yellow fever outbreak amidst a global pandemic

In early November 2020, positive samples for yellow fever were reported from five Nigerian states. Nigeria is a high-risk country for yellow fever and is a priority country for the global eliminate yellow fever epidemics (EYE) strategy.

17 Dec 2021

Hormone levels in the womb before birth linked to the risk of developing migraine in adulthood

Hormone levels in the womb before birth have been potentially linked to the risk of developing migraine in adulthood, reveals a new study of genetic and environmental information from the world's largest database of twins.

16 Dec 2021

Changes in trajectory of long COVID symptoms before vaccination

A new preprint describes the results of a study examining this aspect of the disease.

14 Dec 2021

NRG Oncology CC004 trial: Bupropion does not improve sexual desire for female cancer survivors

Despite preliminary supporting evidence that the dopaminergic agent bupropion might improve sexual desire for female cancer survivors, the NRG Oncology CC004 clinical trial determined that bupropion did not improve outcomes when compared to a placebo.

10 Dec 2021